Medical Xpress 03.10.20 CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Read
Endpoints 12.24.19 The top 10 most popular Endpoints News pieces of 2019 — going viral is a whole new game in biopharma now Read
HemOnc Today 11.25.19 UCLA Opens Clinical Trial of Bispecific CAR T-cell Therapy for Advanced Lymphoma, Leukemia Read
Inside Philanthropy 11.25.19 Status Update: How Facebook’s Billionaires Are Changing the World of Philanthropy Read
Myeloma Research News 11.13.19 CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests Read